Acasă › Cancer ovarian › Florida › Tampa
Studii clinice pentru Cancer ovarian în Tampa, FL
21 studii pentru Cancer ovarian caută participanți în și în jurul orașului Tampa (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
În curs de recrutareFaza 3
- Research Site, Tampa
Study of AVZO-021 in Patients With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Avenzo Therapeutics Recruiting Site, Tampa
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
În curs de recrutareStudiu observațional
- Moffitt Cancer Center, Tampa
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
În curs de recrutareFaza 3
- Moffitt Cancer Center, Tampa
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
În curs de recrutareFaza 1
- Moffitt, Tampa
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
În curs de recrutareFaza 1/2
- Moffitt Cancer Center and Research Institute, Tampa
Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer
În curs de recrutareFaza 1
- Moffitt Cancer Center, Tampa
Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors
În curs de recrutareFaza 1
- Moffitt Cancer Center, Tampa
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
În curs de recrutareFaza 2
- Tampa General Hospital Cancer Institute, Tampa
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
În curs de recrutareFaza 1
- Moffitt Cancer Center, Tampa
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
În curs de recrutare
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Clinical Pre-screening Protocol for Ovarian Cancer
În curs de recrutareStudiu observațional
- Moffitt Cancer Center, Tampa
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1/2
- Moffitt Cancer Center, Tampa
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
În curs de recrutareFaza 1/2
- Moffitt Cancer Center, Tampa
SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
În curs de recrutareFaza 1
- Moffitt Cancer Center, Tampa
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
În curs de recrutareFaza 1/2
- Moffitt Cancer Center, Tampa
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation
În curs de recrutareFaza 1
- H. Lee Moffitt Cancer Center and Research Institute Hospital, Tampa
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
În curs de recrutareFaza 1/2
- Moffitt Cancer Center and Research Institute, Tampa
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
În curs de recrutareFaza 2
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Tampa
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
În curs de recrutareFaza 1
- Exelixis Clinical Site #16, Tampa
Studii pentru Cancer ovarian în alte orașe
- Houston, TX89 studii
- New York City, NY69 studii
- Boston, MA61 studii
- Los Angeles, CA50 studii
- Nashville, TN49 studii
- Arlington, VA46 studii
- Philadelphia, PA44 studii
- Columbus, OH39 studii
- St. Louis, MO38 studii
- Chicago, IL36 studii
- San Antonio, TX31 studii
- Cleveland, OH30 studii
Alte studii în Tampa
- Cancer pulmonar cu celule non-pătrate51 studii
- Cancer de sân43 studii
- Cancer (toate tipurile)39 studii
- Cancer colorectal34 studii
- Leucemie mieloasă acută29 studii
- Cancer metastatic29 studii
- Cancer pulmonar29 studii
- Cancer pancreatic26 studii
- Melanom19 studii
- Sindroame mielodisplastice19 studii
- Cancer de prostată18 studii
- Insuficiență cardiacă18 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.